Samsung RS85 ultrasound system receives FDA 510(k) clearance

The release dated March 23, 2018 is replaced with the following corrected version due to multiple revisions.
The corrected release reads:
The Samsung RS85 premium ultrasound system combines exceptional image quality with advanced ergonomics
NeuroLogica, a subsidiary of Samsung Electronics Co. Ltd., announced that the Samsung RS85 ultrasound system has received FDA 510(k) clearance. The RS85 is the latest expansion of Samsung's revolutionary ultrasound portfolio.
"We are pleased to launch the RS85, a new premium general imaging ultrasound system with superior image quality and usability based on Samsung's advanced ultrasound and radiology technologies," said Philip Sullivan, President and CEO of NeuroLogica. "The RS85 embodies Samsung's commitment to providing leading technologies to healthcare providers by combining our key values of access, accuracy and efficiency."
New noninvasive technique uses blood test to detect brain tumor biomarkers
The release of the RS85 is the latest demonstration of Samsung's leadership in ultrasound. It features an array of improvements, including:
MV-Flow™: Allows for visualization of slow-flow micro vascularized structures, which can be difficult to assess with conventional power Doppler ultrasound. It also provides clinicians an additional way to check lesions for indications of cancer or inflammation.
S-Shearwave Imaging™: Provides new indicators for clinical diagnosis by quantifying the elasticity of tissue or lesions via shearwave elastography, which may help increase the accuracy of diagnosis for breast and liver diseases.
CEUS+: Diagnoses and characterizes lesions in the liver using a contrast agent in adult and pediatric populations.
S-Fusion™: Enables simultaneous localization of a lesion using real-time ultrasound in conjunction with other volumetric imaging modalities such as an MRI or a CT, while expanding its capabilities to the prostate gland for precise, targeted biopsy guidance.
The RS85 was also developed to help decrease user-fatigue and repetitive motions with an enhanced monitor arm and increased range of motion and tilt. These improvements allow the user to position the monitor for optimal viewing and control. Additionally, multi-step actions have been combined into a single step to help reduce keystrokes and repetitive user interface interactions.
"Samsung has built innovative and cutting-edge diagnostic ultrasound products for more than 30 years," said David Legg, Vice President of Sales at NeuroLogica. "We are so confident that our RS85 ultrasound system will perform reliably and be the system that you can depend on for years to come, that we are proud to offer a 5-year warranty standard, at no additional cost."
The release dated March 23, 2018 is replaced with the following corrected version due to multiple revisions.
The corrected release reads:
SAMSUNG RECEIVES FDA CLEARANCE FOR PREMIUM ULTRASOUND SYSTEM RS85
The Samsung RS85 premium ultrasound system combines exceptional image quality with advanced ergonomics
NeuroLogica, a subsidiary of Samsung Electronics Co. Ltd., announced that the Samsung RS85 ultrasound system has received FDA 510(k) clearance. The RS85 is the latest expansion of Samsung's revolutionary ultrasound portfolio.
"We are pleased to launch the RS85, a new premium general imaging ultrasound system with superior image quality and usability based on Samsung's advanced ultrasound and radiology technologies," said Philip Sullivan, President and CEO of NeuroLogica. "The RS85 embodies Samsung's commitment to providing leading technologies to healthcare providers by combining our key values of access, accuracy and efficiency."
New noninvasive technique uses blood test to detect brain tumor biomarkersThe release of the RS85 is the latest demonstration of Samsung's leadership in ultrasound. It features an array of improvements, including:
MV-Flow™: Allows for visualization of slow-flow micro vascularized structures, which can be difficult to assess with conventional power Doppler ultrasound. It also provides clinicians an additional way to check lesions for indications of cancer or inflammation.S-Shearwave Imaging™: Provides new indicators for clinical diagnosis by quantifying the elasticity of tissue or lesions via shearwave elastography, which may help increase the accuracy of diagnosis for breast and liver diseases.CEUS+: Diagnoses and characterizes lesions in the liver using a contrast agent in adult and pediatric populations.S-Fusion™: Enables simultaneous localization of a lesion using real-time ultrasound in conjunction with other volumetric imaging modalities such as an MRI or a CT, while expanding its capabilities to the prostate gland for precise, targeted biopsy guidance.The RS85 was also developed to help decrease user-fatigue and repetitive motions with an enhanced monitor arm and increased range of motion and tilt. These improvements allow the user to position the monitor for optimal viewing and control. Additionally, multi-step actions have been combined into a single step to help reduce keystrokes and repetitive user interface interactions.
"Samsung has built innovative and cutting-edge diagnostic ultrasound products for more than 30 years," said David Legg, Vice President of Sales at NeuroLogica. "We are so confident that our RS85 ultrasound system will perform reliably and be the system that you can depend on for years to come, that we are proud to offer a 5-year warranty standard, at no additional cost."

mce membrane membrane MCE Membrane Filter Sterile MCE gridded membrane filter

MCE Syringe Filter MCE flat membrane MCE membrane application